Houria Ounissi-Benkalha

Title: Houria Ounissi-Benkalha: Innovator in Autoimmune Diabetes Diagnosis

Introduction

Houria Ounissi-Benkalha is a prominent inventor based in St-Laurent, Canada. She has made significant contributions to the field of medical diagnostics, particularly in the prediction of autoimmune diabetes. Her innovative work has the potential to improve the lives of many individuals at risk of this condition.

Latest Patents

Houria holds a patent for a novel DNA assay designed for the diagnosis and prediction of autoimmune diabetes. This invention involves a method that includes obtaining a DNA sample from a subject and amplifying at least one class III allele of variable number of tandem repeats (VNTR) located upstream of the insulin gene (INS). This allele is associated with the silencing of thymic insulin mRNA expression. The process culminates in subjecting the sample to electrophoresis to identify the silencing class III allele. This patent represents a significant advancement in the early detection of autoimmune diabetes.

Career Highlights

Houria Ounissi-Benkalha is affiliated with McGill University, where she continues her research and development in the field of genetics and autoimmune diseases. Her work is characterized by a commitment to scientific excellence and innovation.

Collaborations

Throughout her career, Houria has collaborated with esteemed colleagues, including Constantin Polychronakos and Petros Vafiadis. These partnerships have enriched her research and contributed to the advancement of knowledge in her field.

Conclusion

Houria Ounissi-Benkalha is a trailblazer in the realm of autoimmune diabetes diagnostics. Her innovative DNA assay has the potential to transform how this condition is predicted and diagnosed, ultimately benefiting countless individuals.